Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Pharmos Logo
Pharmos Growth Score
79
CB Rank
929028
Heat Score
27
Pharmos is a bio-pharmaceutical company that discovers and develops new drugs to treat a range of neuroinflammatory disorders.
Founded
obfuscation
PrivateGrant Iselin, New Jersey, United States1-10 pharmoscorp.com/
Biotechnology
Health Care
Therapeutics
Overview

Pharmos
Total Funding
obfuscation
Growth Score
79
Heat Score
27

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score79
-10 pts
in past quarter
Heat Score 27
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Pharmos

CB Rank
929028
Pharmos is a bio-pharmaceutical company that discovers and develops new drugs to treat a range of neuroinflammatory disorders.
Founded
obfuscation
PrivateGrant Iselin, New Jersey, United States1-10 pharmoscorp.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Details

Legal Name Pharmos Corporation
Operating Status Active
Company Type For Profit
About the Company
Pharmos Corporation is a bio-pharmaceutical company that discovers and develops new drugs to treat a range of neuroinflammatory disorders. The company is based in Iselin, New Jersey.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Cannabinor
A CB2-selective receptor agonist drug candidate developed for treating pain, including neuropathic and post-operative pain.
Dextofisopam
A drug candidate under evaluation for treating irritable bowel syndrome (IBS) through modulation of the brain-gut axis.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant
obfuscation
Grant - Pharmos Logo
Grant - Pharmos
1
obfuscation
Israel's Ministry Of Industry, Trade & LaborGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

IT Spend

$19.7KThis year, Pharmos is projected to spend $19.7K on IT, according to Aberdeen.

Actively Used Products

7Pharmos uses 7 technology products and services including HTML5, Google Compute Engine, and  Apache Server, according to G2 Stack.

Active Website Tech Count

3Pharmos is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Pound Sterling.

Total IP

5The intellectual property of Pharmos includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Pharmos's headquarters? Pharmos is located in Iselin, New Jersey, United States.Who invested in Pharmos? Pharmos has 2 investors including Israel's Ministry Of Industry, Trade & Labor and  Institutional Investor.When was the last funding round for Pharmos? Pharmos closed its last funding round on
obfuscation
from a Grant round.Who are Pharmos's competitors? Alternatives and possible competitors to Pharmos may include Aquestive Therapeutics, InMed Pharmaceuticals, and  Lexicon Pharmaceuticals.How much funding has Pharmos raised to date? Pharmos has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|